BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4811085)

  • 1. One-year contraception with norgestrienone subdermal silastic implants.
    Coutinho EM; da Silva AR
    Fertil Steril; 1974 Feb; 25(2):170-6. PubMed ID: 4811085
    [No Abstract]   [Full Text] [Related]  

  • 2. [Egg-laying factor in the hen: 17 alpha-ethylyltrenolone].
    Grandadam JA; Klein G; Dreux H; Deroy R; Bonnemain F; Pottier J; Busigny M
    Ann Nutr Aliment; 1973; 27(3):163-80. PubMed ID: 4766921
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of reproduction and of undesirable social and sexual behaviour in dogs and cats.
    Gerber HA; Jöchle W; Sulman FG
    J Small Anim Pract; 1973 Mar; 14(3):151-8. PubMed ID: 4738952
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of an oral progestin contraceptive, R-2323, 5mg, administered at weekly intervals.
    Mora G; Faundes A; Pastore U
    Contraception; 1974 Aug; 10(2):145-57. PubMed ID: 4421020
    [No Abstract]   [Full Text] [Related]  

  • 5. Contraceptive effectiveness of Silastic implants containing the progestin R-2323.
    Coutinho EM; Da Silva AR; Carreira CM; Chaves MC; Adeodato Filho J
    Contraception; 1975 Jun; 11(6):625-35. PubMed ID: 1137935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dosage oral progestogens to control fertility. I. clinical investigation.
    Zanartu J; Dabancens A; Oberti C; Rodriquez-Bravo R; Garcia-Huidobro M
    Obstet Gynecol; 1974 Jan; 43(1):87-96. PubMed ID: 4587643
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trial with subdermal implants of the progestin R-2323.
    Diaz S; Pavez M; Quniteros E; Robertson DN; Croxatto HB
    Contraception; 1977 Aug; 16(2):155-65. PubMed ID: 913113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical chemistry in women treated with progestogen implants.
    Croxatto HB; Diaz S; Pavez M
    Contraception; 1978 Oct; 18(4):441-50. PubMed ID: 720076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prolonged progestational and anti-estrogenic activity of 6,11beta-dichloro-3beta, 17-dihydroxy-19-nor-4,6-pregnadien-20-one 17-acetate 3beta-benzoate (gr2/2132).
    Gilbert HG; Woollett EA; Child KJ
    Steroids; 1974 Nov; 24(5):731-6. PubMed ID: 4476097
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of an anabolic steroid (Norbolethone) on the function of the isolated perfused rat liver.
    Bassan H; Kendler J; Harinasuta U; Zimmerman HJ
    Biochem Pharmacol; 1971 Jul; 20(7):1429-35. PubMed ID: 5163083
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with implant contraception.
    Coutinho E
    Contraception; 1978 Oct; 18(4):411-27. PubMed ID: 720074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facts about an implantable contraceptive: memorandum from a WHO meeting.
    Bull World Health Organ; 1985; 63(3):485-94. PubMed ID: 3930082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eighteen months contraception following subdermal insertion of silastic capsules containing norgestrienone.
    Da Silva AR; Coutinho EM
    Int J Fertil; 1978; 23(3):185-92. PubMed ID: 40892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach to estrogen-free contraception based on progesterone receptor blockage by mid-cycle administration of ethyl norgestrienone (R 2323).
    Sakiz E; Azadian-Boulanger G; Laraque F; Raynaud JP
    Contraception; 1974 Nov; 10(5):467-74. PubMed ID: 4375015
    [No Abstract]   [Full Text] [Related]  

  • 15. The biological profile of a new synthetic progestagen--GR2-1159-(17-acetoxy-6,11 beta-dichloro-19-nor-4,6-pregnadiene-3,20-dione).
    Child KJ; English AF; Gilbert HG; Woollett EA
    Steroids; 1974 Mar; 23(3):425-42. PubMed ID: 4133334
    [No Abstract]   [Full Text] [Related]  

  • 16. Contraceptive steroid administration by subdermal implants: serum concentrations of R-2323, estrogen and progesterone in rhesus monkeys.
    Bahgat MR; Atkinson LE
    Contraception; 1977 Mar; 15(3):335-45. PubMed ID: 880812
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal uterine bleeding during progestin-only contraception may result from free radical-induced alterations in angiopoietin expression.
    Krikun G; Critchley H; Schatz F; Wan L; Caze R; Baergen RN; Lockwood CJ
    Am J Pathol; 2002 Sep; 161(3):979-86. PubMed ID: 12213726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial with subdermal implants containing norgestrienone.
    Diaz S; Pavez M; Quinteros E; Diaz J; Robertson DN; Croxatto HB
    Contraception; 1978 Oct; 18(4):429-40. PubMed ID: 720075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The remote changes in the endometrial histology and the cervicovaginal cytology with the long acting hormonal contraceptive.
    Sammour MB; El-Hafiz MA
    Fertil Steril; 1970 Jun; 21(6):464-8. PubMed ID: 4927704
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of clomiphene, cyclofenil, epimestrol and Ro 4-8347 on pituitary and serum prolactin in mature female rats.
    Maeda HR; Seki M; Seki K; Yoshihara T
    Endocrinol Jpn; 1972 Dec; 19(6):525-32. PubMed ID: 4679231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.